Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 258281, 14 pages
http://dx.doi.org/10.1155/2015/258281
Research Article

Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma

1Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Hallera 1 Square, 90-647 Lodz, Poland
2The Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
3Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA
4Department of Ophthalmology, Medical University of Warsaw, Sierakowskiego 13 street, 03-709 Warsaw, Poland
5SPKSO Ophthalmic Hospital, Sierakowskiego 13 street, 03-709 Warsaw, Poland

Received 11 December 2014; Revised 6 March 2015; Accepted 10 March 2015

Academic Editor: Janusz Blasiak

Copyright © 2015 Alicja Nowak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Friedman, R. C. Wolfs, B. J. O'Colmain et al., “Prevalence of open-angle glaucoma among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 532–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Kama-Matyjaszek, R. Sierzantowicz, and Z. Mariak, “Acceptance of own disease by patients with diagnosed glaucoma,” Polski Merkuriusz Lekarski, vol. 28, no. 163, pp. 37–41, 2010. View at Google Scholar · View at Scopus
  3. H. A. Quigley and A. T. Broman, “The number of people with glaucoma worldwide in 2010 and 2020,” British Journal of Ophthalmology, vol. 90, no. 3, pp. 262–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Mozaffarieh, M. C. Grieshaber, and J. Flammer, “Oxygen and blood flow: players in the pathogenesis of glaucoma,” Molecular Vision, vol. 14, pp. 224–233, 2008. View at Google Scholar · View at Scopus
  5. J. S. Distelhorst and G. M. Hughes, “Open-angle glaucoma,” American Family Physician, vol. 67, no. 9, pp. 1937–1950, 2003. View at Google Scholar · View at Scopus
  6. N. Gupta and Y. H. Yucel, “Glaucoma as a neurodegenerative disease,” Current Opinion in Ophthalmology, vol. 18, no. 2, pp. 110–114, 2007. View at Google Scholar
  7. A. U. Bayer, O. N. Keller, F. Ferrari, and K.-P. Maag, “Association of glaucoma with neurodegenerative diseases with apoptotic cell death: alzheimer's disease and Parkinson's disease,” American Journal of Ophthalmology, vol. 133, no. 1, pp. 135–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Sadun and C. J. Bassi, “Optic nerve damage in Alzheimer's disease,” Ophthalmology, vol. 97, no. 1, pp. 9–17, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Fisher, D. A. Jacobs, C. E. Markowitz et al., “Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis,” Ophthalmology, vol. 113, no. 2, pp. 324–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Harwerth, A. S. Vilupuru, N. V. Rangaswamy, and E. L. Smith III, “The relationship between nerve fiber layer and perimetry measurements,” Investigative Ophthalmology & Visual Science, vol. 48, no. 2, pp. 763–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. W. Nickells, “Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death,” Survey of Ophthalmology, vol. 43, supplement 1, pp. S151–S161, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. McKinnon, “Glaucoma, apoptosis, and neuroprotection,” Current Opinion in Ophthalmology, vol. 8, no. 2, pp. 28–37, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Garcia-Valenzuela, S. Shareef, J. Walsh, and S. C. Sharma, “Programmed cell death of retinal ganglion cells during experimental glaucoma,” Experimental Eye Research, vol. 61, no. 1, pp. 33–44, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. H. A. Quigley, J. Guy, and D. R. Anderson, “Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve,” Archives of Ophthalmology, vol. 97, no. 3, pp. 525–531, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. E. B. Dreyer, D. Zurakowski, R. A. Schumer, S. M. Podos, and S. A. Lipton, “Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma,” Archives of Ophthalmology, vol. 114, no. 3, pp. 299–305, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Tezel, G. M. Seigel, and M. B. Wax, “Autoantibodies to small heat shock proteins in glaucoma,” Investigative Ophthalmology and Visual Science, vol. 39, no. 12, pp. 2277–2287, 1998. View at Google Scholar · View at Scopus
  17. N. N. Osborne, M. Ugarte, M. Chao et al., “Neuroprotection in relation to retinal ischemia and relevance to glaucoma,” Survey of Ophthalmology, vol. 43, supplement 1, pp. S102–S128, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. H. Kuehn, J. H. Fingert, and Y. H. Kwon, “Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies,” Ophthalmology Clinics of North America, vol. 18, no. 3, pp. 383–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kaul, G. A. Garden, and S. A. Lipton, “Pathways to neuronal injury and apoptosis in HIV-associated dementia,” Nature, vol. 410, no. 6831, pp. 988–994, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Tezel, M. R. Hernandez, and M. B. Wax, “Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes,” Archives of Ophthalmology, vol. 118, no. 4, pp. 511–518, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Tezel, J. Yang, and M. B. Wax, “Heat shock proteins, immunity and glaucoma,” Brain Research Bulletin, vol. 62, no. 6, pp. 473–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. W. Mahley, “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology,” Science, vol. 240, no. 4852, pp. 622–630, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Herz and U. Beffert, “Apolipoprotein E receptors: linking brain development and Alzheimer's disease,” Nature Reviews Neuroscience, vol. 1, no. 1, pp. 51–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Poirier, “Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease,” Trends in Molecular Medicine, vol. 9, no. 3, pp. 94–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wolozin, “Cholesterol and the biology of Alzheimer's disease,” Neuron, vol. 41, no. 1, pp. 7–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. A. Mann, T. Iwatsubo, S. M. Pickering-Brown, F. Owen, T. C. Saido, and R. H. Perry, “Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele,” Neuroscience Letters, vol. 221, no. 2-3, pp. 81–84, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Ayub, M. Imran Khan, S. Micheal et al., “Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts,” Molecular Vision, vol. 16, pp. 18–25, 2010. View at Google Scholar
  28. H. Q. Jiang and J. P. Jia, “Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer's disease in the North Chinese population,” Neuroscience Letters, vol. 450, no. 3, pp. 356–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Wang, J. M. Kwon, P. Shah, J. C. Morris, and A. Goate, “Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease,” Neurology, vol. 55, no. 11, pp. 1644–1649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. Artiga, M. J. Bullido, I. Sastre et al., “Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene,” FEBS Letters, vol. 421, no. 2, pp. 105–108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Dmitrzak-Weglarz, J. K. Rybakowski, A. Suwalska et al., “Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients,” Pharmacogenomics, vol. 9, no. 11, pp. 1595–1603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Faul, E. Erdfelder, A.-G. Lang, and A. Buchner, “G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences,” Behavior Research Methods, vol. 39, no. 2, pp. 175–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. W. Mittag, J. Danias, G. Pohorenec et al., “Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model,” Investigative Ophthalmology and Visual Science, vol. 41, no. 11, pp. 3451–3459, 2000. View at Google Scholar · View at Scopus
  34. L. A. Kerrigan, D. J. Zack, H. A. Quigley, S. D. Smith, and M. E. Pease, “TUNEL-positive ganglion cells in human primary open-angle glaucoma,” Archives of Ophthalmology, vol. 115, no. 8, pp. 1031–1035, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Zhang, X. Qian, C. Redman et al., “p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB,” Oncogene, vol. 22, no. 15, pp. 2285–2295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Yang, T. A. Martin, and W. G. Jiang, “Biological influence of brain-derived neurotrophic factor on breast cancer cells,” International Journal of Oncology, vol. 41, no. 4, pp. 1541–1546, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Schuler and D. R. Green, “Mechanisms of p53-dependent apoptosis,” Biochemical Society Transactions, vol. 29, part 6, pp. 684–688, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Kalita, D. Makonchuk, C. Gomes, J.-J. Zheng, and M. Hetman, “Inhibition of nucleolar transcription as a trigger for neuronal apoptosis,” Journal of Neurochemistry, vol. 105, no. 6, pp. 2286–2299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H. A. Quigley, S. J. McKinnon, D. J. Zack et al., “Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats,” Investigative Ophthalmology and Visual Science, vol. 41, no. 11, pp. 3460–3466, 2000. View at Google Scholar · View at Scopus
  40. M. E. Pease, S. J. McKinnon, H. A. Quigley, L. A. Kerrigan-Baumrind, and D. J. Zack, “Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma,” Investigative Ophthalmology & Visual Science, vol. 41, no. 3, pp. 764–774, 2000. View at Google Scholar · View at Scopus
  41. V. Gupta, Y. You, J. Li et al., “BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma,” Biochimica et Biophysica Acta, vol. 1842, no. 9, pp. 1567–1578, 2014. View at Google Scholar
  42. H. Gao, X. Qiao, F. Hefti, J. G. Hollyfield, and B. Knusel, “Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury,” Investigative Ophthalmology & Visual Science, vol. 38, no. 9, pp. 1840–1847, 1997. View at Google Scholar · View at Scopus
  43. S. Vepsäläinen, E. Castren, S. Helisalmi et al., “Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease,” Journal of Neurology, vol. 252, no. 4, pp. 423–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. C.-U. Pae, A. Chiesa, S. Porcelli et al., “Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia,” Neuropsychobiology, vol. 65, no. 1, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Chidlow, J. P. M. Wood, and R. J. Casson, “Expression of inducible heat shock proteins Hsp27 and Hsp70 in the visual pathway of rats subjected to various models of retinal ganglion cell injury,” PLoS ONE, vol. 9, no. 12, Article ID e114838, 2014. View at Publisher · View at Google Scholar
  46. J. M. K. Kwong, L. Gu, N. Nassiri et al., “AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury,” Gene Therapy, vol. 22, no. 2, pp. 138–145, 2014. View at Publisher · View at Google Scholar
  47. M. He, H. Guo, X. Yang et al., “Functional SNPs in HSPA1A gene predict risk of coronary heart disease,” PLoS ONE, vol. 4, no. 3, Article ID e4851, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Tosaka, Y. Mashima, T. Funayama, and Y. Ohtake, “Association between open-angle glaucoma and gene polymorphism for heat-shock protein 70-1,” Japanese Journal of Ophthalmology, vol. 51, no. 6, pp. 417–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Amaratunga, C. R. Abraham, R. B. Edwards, J. H. Sandell, B. M. Schreiber, and R. E. Fine, “Apolipoprotein E is synthesized in the retina by Müller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells,” Journal of Biological Chemistry, vol. 271, no. 10, pp. 5628–5632, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. J. C. Vickers, J. E. Craig, J. Stankovich et al., “The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma,” Molecular Vision, vol. 8, pp. 389–393, 2002. View at Google Scholar
  51. S. J. McKinnon, D. M. Lehman, L. A. Kerrigan-Baumrind et al., “Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension,” Investigative Ophthalmology & Visual Science, vol. 43, no. 4, pp. 1077–1087, 2002. View at Google Scholar · View at Scopus
  52. B. Copin, A. P. Brézin, F. Valtot, J.-C. Dascotte, A. Béchetoille, and H.-J. Garchon, “Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene,” The American Journal of Human Genetics, vol. 70, no. 6, pp. 1575–1581, 2002. View at Publisher · View at Google Scholar · View at Scopus